← Leaderboards
Chang-Gyu Hahn
Thomas Jefferson University
$12,209,588
Attributed
$16,714,933
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,714,933 · 11
By mechanism
R01$13,045,921 · 5
P50$1,479,178 · 1
R21$904,813 · 2
K23$882,835 · 1
S10$243,686 · 1
R03$158,500 · 1
Top collaborators
- Steven J Siegel6 shared
- Bruce I Turetsky5 shared
- Hoau-Yan Wang4 shared
- Karin Borgmann-Winter2 shared
- Matthew B Dalva1 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Matthew B Dalva$15,589,714
- Martin Hruska$1,597,893
- Hoau-Yan Wang$1,895,662
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexSignal TransductionMediatingMolecularBrainN-Methyl-D-Aspartate ReceptorsSchizophreniaResponseN-MethylaspartateAutopsyTissuesPathway InteractionsFunctional DisorderDensityNeuronsProteinsPostsynapticLeadPrefrontal CortexBrain RegionCellsBaseGlutamatesLink
Grant awards (42)
Pathophysiologic roles of protein-protein interactions at excitatory synapses and their modifications in schizophrenia$706,404
R01 · FY2025 · MH · contact PI
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$609,276
R01 · FY2024 · MH · contact PI
Cell type specific analysis of Src kinase-NMDA receptor complexes in schizophrenia$429,000
R21 · FY2024 · MH · contact PI
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$609,276
R01 · FY2023 · MH · contact PI
Olfactory neuroepithelial cell derived induced neurons for study of schizophrenia$475,813
R21 · FY2023 · MH · contact PI
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$609,276
R01 · FY2022 · MH · contact PI
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$647,997
R01 · FY2021 · MH · contact PI
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$687,952
R01 · FY2019 · MH · contact PI
Src hypoactivity as a mediator of various molecular alterations leading to NMDAR$214,870
R01 · FY2019 · MH · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$166,343
R01 · FY2019 · MH · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$388,341
R01 · FY2018 · MH · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$389,781
R01 · FY2017 · MH · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$389,781
R01 · FY2016 · MH · contact PI
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients$294,033
P50 · FY2016 · MH · contact PI
Olfactory Evoked Potentials and Developmental Neuropathology in Schizophrenia$694,003
R01 · FY2015 · MH
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$463,092
R01 · FY2015 · MH · contact PI
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients$292,837
P50 · FY2015 · MH · contact PI
Olfactory Evoked Potentials and Developmental Neuropathology in Schizophrenia$644,897
R01 · FY2014 · MH
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients$294,548
P50 · FY2014 · MH · contact PI
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients$1
P50 · FY2014 · MH · contact PI
Olfactory Evoked Potentials and Developmental Neuropathology in Schizophrenia$619,102
R01 · FY2013 · MH
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients$304,921
P50 · FY2013 · MH · contact PI
Acquisition of triple quadrupole mass spectrometer for quantitative proteomics$243,686
S10 · FY2013 · OD · contact PI
Olfactory Evoked Potentials and Developmental Neuropathology in Schizophrenia$627,197
R01 · FY2012 · MH
Lithium responsiveness$540,168
R01 · FY2012 · MH · contact PI
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients$292,838
P50 · FY2012 · MH · contact PI
Olfactory Evoked Potentials and Developmental Neuropathology in Schizophrenia$604,942
R01 · FY2011 · MH
Lithium responsiveness$540,331
R01 · FY2011 · MH · contact PI
Lithium responsiveness$545,962
R01 · FY2010 · MH · contact PI
Lithium responsiveness$543,931
R01 · FY2009 · MH · contact PI
Neuregulin 1-erbB signaling in schizophrenia$307,751
R01 · FY2009 · MH · contact PI
Lithium responsiveness$560,267
R01 · FY2008 · MH · contact PI
Neuregulin 1-erbB signaling in schizophrenia$307,786
R01 · FY2008 · MH · contact PI
Neuregulin 1-erbB signaling in schizophrenia$307,821
R01 · FY2007 · MH · contact PI
Neuregulin 1-erbB signaling in schizophrenia$319,374
R01 · FY2006 · MH · contact PI
Olfactory neurons from bipolar patients$176,653
K23 · FY2006 · MH · contact PI
Olfactory neurons from bipolar patients$176,609
K23 · FY2005 · MH
Olfactory neurons from bipolar patients$176,566
K23 · FY2004 · MH
Olfactory neurons from bipolar patients$176,524
K23 · FY2003 · MH
Olfactory neurons from bipolar patients$176,483
K23 · FY2002 · MH
STUDY OF BIPOLAR DISORDER$79,250
R03 · FY2001 · MH
STUDY OF BIPOLAR DISORDER$79,250
R03 · FY2000 · MH